PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

JOHNSON & JOHNSON's Holding History (CIK: 0000200406)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 2,449,183 Value ($000) $213,912 Avg Close $81.85 Range $62.24 - $96.54
Q3 2025
Shares 2,449,183 Value ($000) $162,699 Avg Close $56.84 Range $49.38 - $68.26
Q2 2025
Shares 2,449,183 Value ($000) $136,395 Avg Close $47.99 Range $39.60 - $57.70
Q1 2025
Shares 2,449,183 Value ($000) $118,442 Avg Close $41.90 Range $33.70 - $60.60
Q4 2024
Shares 2,449,183 Value ($000) $94,538 Avg Close $43.60 Range $33.31 - $48.89
Q3 2024
Shares 2,449,183 Value ($000) $110,213 Avg Close $40.40 Range $32.50 - $48.00
Q2 2024
Shares 2,449,183 Value ($000) $84,864 Avg Close $29.29 Range $24.22 - $35.96
Q1 2024
Shares 2,449,183 Value ($000) $70,855 Avg Close $27.21 Range $21.43 - $33.34
Q4 2023
Shares 2,449,183 Value ($000) $56,160 Avg Close $17.50 Range $13.72 - $23.88
Q3 2023
Shares 2,449,183 Value ($000) $40,852 Avg Close $19.40 Range $16.33 - $26.81
Q2 2023
Shares 2,449,183 Value ($000) $67,646 Avg Close $25.03 Range $17.64 - $30.10
Q1 2023
Shares 2,449,183 Value ($000) $56,331 Avg Close $16.79 Range $10.62 - $25.69
Q4 2022
Shares 2,449,183 Value ($000) $27 Avg Close $8.44 Range $7.24 - $11.46
Q3 2022
Shares 2,449,183 Value ($000) $20,647 Avg Close $9.46 Range $7.68 - $11.97
Q2 2022
Shares 2,449,183 Value ($000) $19,373 Avg Close $12.09 Range $6.91 - $25.76
Q1 2022
Shares 2,449,183 Value ($000) $57,997 Avg Close $28.17 Range $22.56 - $37.05
Q4 2021
Shares 2,449,183 Value ($000) $83,762 Avg Close $31.61 Range $17.26 - $38.11
Q3 2021
Shares 2,449,183 Value ($000) $43,400 Avg Close $42.63 Range $12.80 - $50.54